维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="LOUNIS N"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The challenge of new drug discovery for tuberculosis 显示文摘	Koul A Arnoult E Lounis N	2011	Nature2011，469，：	1
2	Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis显示文摘	Ibrahim M Andries K Lounis N	2007	Antimicrob Agents Chemother2007，51，3：	1
3	Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model显示文摘	Lounis N Gevers T Van Den Berg J	2008	Antimicrob Agents Chemother2008，52，10：	1
4	In vitro and in vivo activities of moxifloxacin and clinafloxacin against mycobacterium tuberculosis 显示文摘	JI B LOUNIS N MASLO C	1998	Antimicrob Agents Chemother1998，42，8：	1
5	Effectiveness of once-weekly rifapentine and moxifloxacin regimens against mycobacterium tuberculosis in mice 显示文摘	LOUNIS N BENTOUCHA A TRUFFOT-PERNOT C	2001	Antimicrob Agents Chemother2001，45，12：	1
6	R207910 (TMC207): A new antibiotic for the treatment of tuberculosis 显示文摘	Lounis N Guillemont J Veziris N	2010	Med Mal Infect2010，40，7：	1
7	In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infections显示文摘	Lounis N Roscigno G	2004	Curr Pharm Des2004，10，：	1
8	The challenge of new drug discovery for tuberculosis 显示文摘	Koul A Arnoult E Lounis N	2011	Nature2011，469，：	1
9	Invitro and in vivo activities of moxifloxacin and clinafloxacin against mycobacterium tuberculosis显示文摘	lounis n maslo c	1998	Antimicrob agents chemother1998，42，：	1
10	Iron and Myco- bacteium tuberculosis infection显示文摘	Lounis N Truffot-Pernot C Grosset J	2001	J Clin Virol2001，20，3：	1
11	Essentiality of FASII pathway for Staphylococcus aureus显示文摘	BALEMANS W LOUNIS N GILISSEN R		0，，：	1
12	In vitro and in vivo activity of moxifloxacin and clinafloxacin against mycobacterium tuberculosis显示文摘	Ji B Lounis N Maslo C	1998	Antimicrob Agents Chemother1998，42，8：	1
13	Clarithro-mycin is inactive againstmycobacterium tuberculosis显示文摘	Truffot Pernot C Lounis N Grosset JH	1995	Antimicrob Agents Chemother1995，39，12：	1
14	The challenge of new drug discovery for tuberculosis显示文摘	Koul A Arnoult E Lounis N	2011	Nature2011，469，7331：	1
15	A Once-weekly R20791 0-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis显示文摘	Veziris N Ibrahim M Lounis N	2009	Am J Respir Crit Care Med2009，179，1：	1
16	In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis 显示文摘	Ji B Lounis N Maslo C TruffobPemot C Bonnafous P Grosset J	1998	Antimicrob Agents Chemother1998，42，8：	1
17	Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration显示文摘	Lounis N Gevers T Van Den Berg J	2006	Antimicrob Agents Chemother2006，50，：	1
18	The challenge of new drug discovery for tuberculosis显示文摘	Koul A Arnoult E Lounis N	2011	Nature2011，469，7331：	1
19	Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice 显示文摘	Lounis N Bentoucha A Truffot-Pemot C	2001	Antimierob Agents Chemother2001，45，12：	1
20	A diaryl quinoline drug active on the ATP synthase of My cobacterium tuberculosis显示文摘	Andries K Verhasselt P Guillemont J Gohlmann H W H Neefs J M Winkler H VanGestel J Timmerman P Zhu M Lee E Williams P de Chaffoy D Huitric E Hoffner S Cambau E Truffot-Pernot C Lounis N Jarlier V	2005	Science2005，307，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示